BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16932724)

  • 1. Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies.
    Gaston H
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):383-92. PubMed ID: 16932724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
    Khare SD; Luthra HS; David CS
    Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.
    Dhaenens M; Fert I; Glatigny S; Haerinck S; Poulain C; Donnadieu E; Hacquard-Bouder C; André C; Elewaut D; Deforce D; Breban M
    Arthritis Rheum; 2009 Sep; 60(9):2622-32. PubMed ID: 19714626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
    Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
    J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HLA-B27 in spondyloarthritis.
    Taurog JD
    J Rheumatol; 2010 Dec; 37(12):2606-16. PubMed ID: 21123333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
    Atagunduz P; Appel H; Kuon W; Wu P; Thiel A; Kloetzel PM; Sieper J
    Arthritis Rheum; 2005 Mar; 52(3):892-901. PubMed ID: 15751060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
    Kollnberger S; Bird L; Sun MY; Retiere C; Braud VM; McMichael A; Bowness P
    Arthritis Rheum; 2002 Nov; 46(11):2972-82. PubMed ID: 12428240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27 and the pathogenesis of spondyloarthropathies.
    López de Castro JA
    Immunol Lett; 2007 Jan; 108(1):27-33. PubMed ID: 17129613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells.
    Kapasi K; Inman RD
    J Immunol; 1992 Jun; 148(11):3554-9. PubMed ID: 1588045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.
    Milia AF; Ibba-Manneschi L; Manetti M; Benelli G; Messerini L; Matucci-Cerinic M
    Ann N Y Acad Sci; 2009 Sep; 1173():570-4. PubMed ID: 19758201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies.
    Mear JP; Schreiber KL; Münz C; Zhu X; Stevanović S; Rammensee HG; Rowland-Jones SL; Colbert RA
    J Immunol; 1999 Dec; 163(12):6665-70. PubMed ID: 10586062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of ankylosing spondylitis: current concepts.
    Smith JA; Märker-Hermann E; Colbert RA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):571-91. PubMed ID: 16777583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice.
    Nickerson CL; Luthra HS; David CS
    Ann Rheum Dis; 1990 Jun; 49 Suppl 1():426-33. PubMed ID: 2115764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
    Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of HIV to AIDS: a protective role for HLA-B27?
    den Uyl D; van der Horst-Bruinsma IE; van Agtmael M
    AIDS Rev; 2004; 6(2):89-96. PubMed ID: 15332431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?
    Neumann-Haefelin C
    Curr Opin Rheumatol; 2013 Jul; 25(4):426-33. PubMed ID: 23656712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis.
    Mathieu A; Paladini F; Vacca A; Cauli A; Fiorillo MT; Sorrentino R
    Autoimmun Rev; 2009 Mar; 8(5):420-5. PubMed ID: 19185064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much HLA-B27 expression is needed for spondyloarthritis?
    Gaston JS
    J Rheumatol; 2008 May; 35(5):738-40. PubMed ID: 18464315
    [No Abstract]   [Full Text] [Related]  

  • 19. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of HLA-B27-associated diseases.
    Breban M; Hacquard-Bouder C; Falgarone G
    Curr Mol Med; 2004 Feb; 4(1):31-40. PubMed ID: 15011957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.